<DOC>
	<DOCNO>NCT02159196</DOCNO>
	<brief_summary>The purpose multi-center randomize control non-inferiority trial determine effect strategy use routine nebulisation mucolytics bronchodilator ( four time daily ) compare strategy use nebulisation mucolytics bronchodilator clinical indication ( i.e . occurrence persistent thick tenacious sputum bronchospasm ) mechanically ventilate intensive care patient . The investigator examine effect term ventilator-free day , define number day alive free ventilation day 28 start ventilation . We hypothesize strategy use nebulisation mucolytics bronchodilator clinical indication inferior strategy use preventive nebulisation mucolytics bronchodilator regard number ventilator free day ICU patient day 28 .</brief_summary>
	<brief_title>Effectiveness Routine Nebulization Mucolytics Bronchodilators During Mechanical Ventilation</brief_title>
	<detailed_description>Detailed Description clinical trials.gov : Design : This investigator-initiated , multi-center , randomize , control , parallel two group , non-inferiority trial intubate ventilated adult ICU patient . A total 950 patient least six participate center include . Consecutive intubate ventilated adult intensive care patient anticipate ventilation duration minimal 24 hour recruit ICU admission onset ventilation . Methods : Patients randomize receive either : 'routine nebulisation ' , i.e . nebulisation mucolytics bronchodilator , administer every 6 hour ( i.e. , 4 time per day ) complete duration ventilation , 'nebulisation strict clinical indication ' , i.e . nebulisation mucolytics case occurrence persistent thick tenacious sputum , active humidification set . Nebulisation bronchodilator case occurrence bronchospasm sign symptom bronchospasm ( wheeze , increase airway pressure , increase airway resistance , slop curve de end tidal CO2 monitoring ) confirm . The decision start nebulisation evaluate daily . In case clinical indication longer exist , therapy stop . Patients randomly assign 1:1 ratio one nebulisation strategy within 24 hour ICU admission intubation , informed consent sign patient patient 's legal representative . Randomization perform use dedicate , password protect , SSL-encrypted website . Randomization sequence generate dedicated computer randomization software program use random block size stratify per center . Due nature intervention blind caregiver possible . Data analysis perform blinded type intervention . Standard care : standard care provide follow local guideline participate center . Recommendations make mechanical ventilation : Attending physician advise use lung-protective ventilation strategy , include use low tidal volume ( ≤ 6 mL/kg predict body weight ) and/or low airway pressure ( ≤ 30 cmH2O ) . Levels positive end-expiratory pressure ( PEEP ) inspire oxygen ( FiO2 ) titrate partial pressure oxygen ( PaO2 ) , preferably use PEEP/ FiO2-table . If spontaneous ventilation well tolerate use till end ventilation . Thereafter , wean ventilation perform stepwise lower pressure-support level . Daily assessment patient 's readiness wean perform . Monitoring : monitoring patient safety review safety issue perform designated independent Data Safety Monitoring Board ( DSMB ) . The DSMB watch ethic conduct study accordance Declaration Helsinki . All ( serious ) adverse event ( SAE ) collect local investigator send designate SAE manager , present event DSMB evaluation . Interim analysis : An interim analysis safety perform first one third ( 193 ) two third ( 388 ) study population , respectively , include complete follow primary outcome . The main concern occurrence tube related incident non-nebulized group , development ventilator associate pneumonia nebulisation group . Serious adverse event ( SAEs ) death , ventilator associate pneumonia , ARDS , new onset ventricular tachyarrhythmia hemodynamic instability wherefore intervention indicate tube occlusion possibly relate study intervention compare . Data collection : Data collect inclusion , daily till day 28 ICU admission intubation day 90 ICU admission intubation . Data collection perform investigator blind randomization group , except day 90 patient discharge . In case follow-up perform telephone . Data cod patient identification number ( PIN ) code keep safe local site . The data transcribe local investigator internet base electronic case record form ( CRF ) . Sample size calculation : Group size calculation focus demonstrate non-inferiority . When sample size group 445 ( 890 patient total ) , one-sided non-inferiority test ( targeted 0.05 ) log-transformed normalize data 80 % power reject null hypothesis number ventilator-free day ( VFDs ) intervention group ( nebulisation strict clinical indication ) inferior number VFDs control group ( routine nebulisation ) margin 10 % coefficient variation 0.70 , favor alternative hypothesis number VFDs intervention group non-inferior . The choice margin 10 % motivate consider acceptable clinical point view maximal acceptable reduction ventilator-free period non-inferiority . Clinically margin mean increase &gt; 10 % duration mechanical ventilation reduce ventilator free day &gt; 12 hour ( calculated mean duration mechanical ventilation 5 day ) consider inferior , assume data analyze log scale use t-test difference mean 5 % level . To allow anticipated drop approximately 5 % , number 475 ( 950 total ) . As randomized control trial , expect randomization large study population sufficiently balance baseline characteristic . However imbalance occurs , Cox proportional hazard model use adjust accordingly . The effect nebulisation primary outcome investigate pre-specified subgroup base humidification method ( active passive ) , different type nebuliser continuous versus breath actuate nebulisation . Time event variable : Time event variable interest ( mortality , extubation , tracheotomy , VAP , ARDS , tube occlusion ) analyze use Cox regression visualize Kaplan-Meier . If 95 % CI upper bound inferiority nebulized-on-indication group &lt; 10 % , null hypothesis inferiority reject . If non-inferiority criterion satisfy , superiority primary endpoint , number ventilator free day test . Organization : The study conduct FP , JB , MJS SMvdH . SMvdH FP lead project . They provide assistance participate clinical site trial management , record keep data management . Local investigator site perform randomization , supervise data collection ensure adherence Good Clinical Practice trial .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>Expectorants</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Age 18 year older Expected duration intubation ventilation &gt; 24 hour Written inform consent Age le 18 year Ventilation present ICU admission ( though shortterm ventilation emergency room operation room general anesthesia surgery allow ) Suspected confirmed pregnancy Diagnosed lung disease inhalation therapy and/or oral steroid use Diagnoses : GuillainBarré syndrome , complete spinal cord lesion amyotrophic lateral sclerosis , Multiple Sclerosis , Myasthenia Gravis Known allergy acetylcysteine salbutamol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>mechanical ventilation</keyword>
	<keyword>nebulisation</keyword>
	<keyword>respiratory failure</keyword>
</DOC>